Skip to main content
S 5059 119th Congress Senate Health

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Introduced: July 21, 2026 Introduced by: Moody, Ashley Republican · Florida See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2026
Introduced in Senate
Jul 21, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now July 21, 2026

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 5059: A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.. 119th Congress. Open America. https://openamerica.io/bill/119-S-5059/
MLA
"S. 5059: A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-5059/.
Bluebook (legal)
S. 5059, 119th Cong. (2026), https://openamerica.io/bill/119-S-5059/.
Markdown link
[S. 5059: A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.](https://openamerica.io/bill/119-S-5059/)
Report a problem